Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response

This study aimed to evaluate the efficacy of 18-month 0.01% atropine in 61 myopic children (aged 7–10) and the relationship with central retinal response (by multifocal electroretinogram [mfERG]) in a double-masked randomized placebo-controlled clinical trial. Global-flash mfERG was measured at base...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Henry H. L., Choi, Kai Yip, Ng, Alex L. K., Choy, Bonnie N. K., Chan, Jonathan Cheuk Hung, Chan, Sonia S. H., Li, Serena Z. C., Yu, Wing Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270320/
https://www.ncbi.nlm.nih.gov/pubmed/35804049
http://dx.doi.org/10.1038/s41598-022-15686-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270320/
https://www.ncbi.nlm.nih.gov/pubmed/35804049
http://dx.doi.org/10.1038/s41598-022-15686-6

Ejemplares similares